Antibodies
to neuropeptide receptors can be used to localize and characterize the receptors in tissues and cell lines. Two strategies were used to study the rat substance P receptor (SPR, NK-1) by immunological methods. First, a polyclonal antiserum was raised by immunizing rabbits with a peptide corresponding to the 15 amino acid residues (KTMTESSS-FYSNMLA, SPR,,,_,,,) at the intracellular C-terminus of the rat SPR coupled to bovine thyroglobulin.
An antiserum was obtained with a titer for half-maximal binding of '251-SPR,,,,,, of 1:70,000. Nonradioactive SPR,,,,,, inhibited 50% of binding at a concentration of 10 PM. Binding of '251-SPR,,,,,, to the antiserum was also displaced in a parallel manner by membrane proteins from tissues expressing high levels of the SPR (brain and submaxillary gland). Second, a chimeric SPR construct of a hydrophilic Flag peptide (DYKDDDDK) genetically engineered in sequence with the extracellular N-terminus of rat SPR was generated by polymerase chain reaction. The Flag-SPR chimera was expressed in rat kidney epithelial cells (KNRK) and judged to be fully functional, assessed by binding of 1251-substance P (apparent Kd of 5.63 nM) and calcium mobilization in response to substance P (EC,, of 0.66 nM). Antibodies to SPR,,,-,,, and the Flag peptide stained the plasma membrane of KNRK cells expressing the native SPR or the Flag-SPR chimera. Staining was abolished by preincubation with SPR,,,,,, or the Flag peptide. Cells transfected with vector alone were unstained. The SPR antiserum recognized a broad protein band on Western blots of membranes prepared from cells expressing SPR but not from cells transfected with vector alone. The signal was quenched by preincubation of the antiserum with SPR,,,,,,. By immunohistochemistry, the SPR antiserum was found to bind to neurons in the dorsal horn of the rat spinal cord and to ganglion cells in the myenteric plexus of the rat ileum near substance P-immunoreactive nerve fibers. Staining was abolished by preabsorption of the antiserum with SPR,,,,,,.
The neuropeptide substance P belongs to the tachykinin family of peptides that share the C-terminal sequence -Phe-X-Gly-LeuMet-NH? (Erspamer, 198 1) . In mammals the tachykinin family includes substance P, neurokinin A (substance K), and neurokinin B (neuromedin K). Substance P is widely expressed in the PNS and CNS (Hiikfelt et al., 1975; Schultzberg et al., 1980) where it affects smooth muscle contraction, exocrine gland secretion, vascular permeability, and neurotransmission (for reviews, see Helke et al., 1990; Otsuka and Yoshioka, 1993) . Substance P exerts its biological actions by a high-affinity interaction with the substance P or NK-1 receptor (SPR), although at higher concentrations it also interacts with the NK-2 and NK-3 receptors (Helke et al., 1990) . The amino acid sequences of the rat (Yokota et al., 1989; Hershey and Krause, 1990) , human (Gerard et al., 1991; Hopkins et al., 199 l) , and mouse (Sundelin et al., 1992 ) SPR have been deduced by molecular cloning. The receptors show marked similarity at the amino acid level, and contain within their sequence seven domains of hydrophobic amino acid residues that are presumed to span the plasma membrane. Thus, the SPR belongs to the family of G-protein-coupled receptors with seven hydrophobic domains (Yokota et al., 1989; Hershey and Krause, 1990) . Examination ofthe function ofthe tachykinin receptors would be facilitated by the availability of specific antibodies that could be used to localize the receptors throughout the body by immunohistochemistry and for the immunological characterization of the SPR in cell lines. However, there are few reports of such antibodies despite the recent progress that has been made in cloning and sequencing the receptors. We report two complementary strategies for studying the SPR by immunochemical methods. The first strategy depended on the generation of a polyclonal antibody to a synthetic fragment of the intracellular C-terminus ofthe rat SPR coupled to bovine thyroglobulin. The antibody was suitable for radioimmunoassay, immunohistochemistry, and Western blotting. The second strategy involved the generation of a chimeric receptor composed of the rat SPR and an N-terminal, hydrophilic Flag peptide. A high-affinity monoclonal antibody to the Flag peptide was then used to study the chimeric receptor in transfected cells by immunohistochemistry. This latter approach was first used as a marker for the identification and purification of recombinant lymphokines from yeast supernatants and Escherichia coli extracts (Hopp et al., 1988) but has not previously been used to study tachykinin receptors.
Reports of the generation and characterization of antibodies to the rat NK-1 receptor were published during the preparation of this article (Moussaoui et al., 1992; Shigemoto et al., 1993) .
Materials and Methods
Materials. The rat SPR cDNA (Yokota et al., 1989) in pBluescript (Strataaene. La Jolla. CA) was obtained from Dr. S. Nakanishi fUniversity-of Kyoto, Japan). 'The mammalian expression vectors pcDNA I Neo and pRC/CMV were from Invitrogen Corp., San Diego, CA. Molecular biology grade enzymes for generation of the Flag-SPR construct and for subcloning were from Boehringer-Mannheim, Indianapolis, IN. The Flag M2 antibody was from 1nte;national Biotechnologies, Inc.. New Haven. CT. Rhodamine (TRITC)-coniueated aoat anti-rabbit IgG'and fluorescein (FITC)-conjugated goat anti-mouse'igG were from Cappel Research Products, Durham, NC. The Vector Elite staining kit was from Vector Laboratories, Burlingame, CA. The substance P antiserum was from Incstar, Stillwater, MN. Alkaline phosphatase-conjugated goat anti-rabbit IgG was from Cappel, West Chester, PA: BoltonHunter labeled 'z51-substance P (2000 Ci/mmol), liquid purple, and rainbow molecular weight markers were from Amersham Corp., Arlington Heights, IL. Ponceau S was from Sigma Chemical Co., St. Louis, MO. Kirsten murine sarcoma virus transformed rat kidney cells (KNRK) were from American Type Tissue Culture Collection, Rockville, MD. Cell Dissociation Buffer (PBS based, enzyme free), Dulbecco's modified Eagle medium (DMEM), Opti-MEM, lipofectin, and G418 were from GIBCO/Bethesda Research Labs, Gaithersburg, MD. Substance P was from Peninsula Laboratories Inc., San Carlos, CA. Fura-Z/AM was from Molecular Probes, Eugene, OR. A solution of human plasma proteins (plasmanate) was from Baxter Healthcare, Glendale, CA. Activated charcoal was from Mallinckrodt, Paris, KY.
Generation of the Flag-SPR construct. Two oligonucleotides were designed as primers for the polymerase chain reaction (PCR; Fig. 1A ).
The 5' primer (I), in the sense orientation, was designed to contain an XbaI restriction site, an initiation consensus sequence, the Flag sequence, and 27 nucleotides of the rat SPR cDNA (starting at the initiation codon, 555-58 1). The 3' primer (II), in the antisense orientation, was homologous to a 24 nucleotide sequence of the rat SPR cDNA (777-799) containing a unique StuI restriction site (788) (789) (790) (791) (792) (793) (794) (795) (796) . A 289 base pair fragment was generated by standard PCR methodology using the rat SPR cDNA and the two oligonucleotide primers (Fig. 1B) . The PCR fragment was digested using the restriction enzymes XbaI and StuI and gel purified. The rat SPR cDNA in pBluescript was also digested with XbaI and StuI and gel purified. The XbaI-StuI digested PCR fragment and the linearized plasmid bearing the cohesive XbaI and StuI termini were ligated to oroduce uBluescrint Flag-SPR cDNA. Transformants were screened-by double-stranded DNA sequence analysis. Both DNA strands were sequenced using an oligonucleotide corresponding to the 81 I-831 antisense sequence of the rat SPR cDNA and the T3 promoter sequence of the multiple cloning site of pBluescript. Two clones were isolated verifying the correct sequence of the Flag-SPR construct.
The Flag-SPR construct in pBluescript was subcloned into pcDNA I Neo for expression studies (Fig. 1C) . Flag-SPR was excised using the restriction enzyme Not1 and subcloned into the Not1 site of the expression vector pcDNA I Neo to create pcDNA I Neo Flag-SPR.
Transfection oftheSPR and Flag-SPR chimera into mammalian cells. KNRK cells were cultured in DMEM containing 100 ml/liter fetal calf serum, 100 U/ml penicillin, and 100 pg/ml streptomycin at 37°C in 5% CO,, 95% air. Cells were transfected by lipofection (Felgner et al., 1987) with one of the following plasmids: (1) pcDNA I Neo Flag-SPR (Fig.  lC) , (2) PAW SPR or (3) pRC/CMV as the vector-only control. DNA (5 pg) was added to I ml of Opti-MEM, and lipofectin (20 3) was also added to I ml of Opti-MEM. Cells (-80% confluent) were washed twice with Opti-MEM. Lipofectin solution was mixed with the DNA solution and Figure 1 . Generation and subcloning of the Flag-substance P receptor construct.
added to the cells. Cells were incubated overnight at 37°C washed, split, and maintained in culture medium for 48 hr. Cells were placed into antibiotic selection with 400 fig/ml G4 18 in culture medium (changed every 4 d). After 10 d of selection, visible colonies were cloned into selection medium. Positive clones were identified by immunohistochemistry and calcium signal transduction (see below) and maintained in culture medium containing 400 &ml G4 18.
Generation of SPR antis&a. Antisera were raised to a peptide (KTMTESSSFYSNMLA) corresnondine to the carboxv-terminal 15 amino acid residues of the rat SPR (SPR 393-407), which was synthesized by automated solid-phase peptide synthesis using FMOC/BOP chemistry. The peptide was purified by reversed-phase high-pressure liquid chromatography, and the correct mass was confirmed by mass spectrometry. The peptide was conjugated to bovine thyroglobulin using glutaraldehyde (Dockray et al., 198 1) . The efficiency of conjugation was 94% as monitored by incorporation of iodinated SPR,,,,,, into the conjugate.
Three 2 kg male rabbits (New Zealand White) were immunized with 85 nmol of SPR 393A07 equivalents ofthe conjugate, emulsified with complete Freund's adjuvant, by multiple intradermal injections on the back. The animals were boosted at monthly intervals with 40 nmol of SPR,,,,,, equivalents of the conjugate, emulsified in incomplete Freund's adjuvant, and bled from the central ear artery 10 d after each boost. Serum was prepared and stored at -80°C. The sera were tested P Receptor Antibodies for anti-SPR,,,,,, antibodies by radioimmunoassay (see below). '251-SPRwm, was incubated with various dilutions of sera overnight followed by separation of antibody-bound from free 'zSI-SPR,,,,,, by precipitation using activated charcoal. The fifth bleed from rabbit 11884 (antiserum 11884-5) yielded a titer for half-maximal binding of i251-SPR ,,,,-407 of 1:70,000. Nonradioactive SPR,,,,,, at a concentration of 10 PM inhibited 50% of the 1151-SPR,,,,,, binding. This antiserum was used in all studies reported in this communication.
Radioimmunoassay of the SPR. Synthetic SPR,,,,,, was iodinated by the chloramine T method (Hunter and Greenwood, 1962) and purified by reversed-phase high-performance liquid chromatography. The radioimmunoassay buffer was 70 mM sodium phosphate, containing 6 gm/liter sodium chloride, 0.2 gm/liter sodium azide, and 1 ml/liter of a 50 gm/liter solution of human plasma proteins (plasmanate). Label (3000 cpm of 1251-SPR,,,,,, ) and antiserum 11884-5 (final dilution of 1:70,000) were added to a final volume of 1 ml. Antibody-bound 1251-SPR,,,,,, was separated from free '251-SPR,,,,,, by adding 150 ~1 of a 22.5 gm/liter suspension of activated charcoal in assay buffer containing 100 ml/liter plasmanate, and centrifuged at 3000 rpm for 10 min at 4°C. Tissue extracts were prepared for radioimmunoassay. Rat brain, submaxillary glands, liver, and spleen were separately minced and homogenized (1: 10 v/v) in ice-cold 50 mM Tris-HCl, pH 7.5, containing 1 rnM EDTA, 1 mM EGTA, and 0.1 mM phenylmethylsulfonyl fluoride (PMSF). The homogenates were centrifuged at 1000 x g,,, for 10 min at 4°C. The pellets were discarded and the supernatants were recentrifuged at 30,000 x g,,,, for 30 min at 4°C. The pellets were then resuspended in 10 vol of the same buffer and centrifuged again at 35,000 x g,,, for 30 min at 4°C and the pellets were resuspended in the same buffer. The membranes were stored at -80°C until assay. After thawing, the membranes were resuspended and centrifuged at 35,000 x g,,,,, for 15 min at 4°C. The membrane pellets were resuspended at a final concentration of 1 mg of membrane protein/ml in 1 ml/liter Triton X-100, boiled for 5 min, and centrifuged for I min at 8700 x g,,,. The supernatants were used in the SPR radioimmunoassay. KNRK cells for radioimmunoassay were grown to confluence in 12-well plates and extracted with 0.2 ml of 1 ml/liter Triton X-100 as described for the tissue samples.
Immunohistochemistvy. Transfected KNRK cells, grown on coverslios. were rinsed in 100 mM ohosohate-buffered saline (PBS), pH 7.4, &~. and fixed in 40 gm/liter paraformaidehyde in PBS, pH 714, for i0 min. Cells were washed three times in PBS containing 10 ml/liter normal goat serum. Because the SPR antiserum 11884-5 was raised to an intracellular portion of the receptor, the cell membranes were permeabilized with 1 gm/liter saponin added to all buffers. The intensity of staining was markedly reduced if saponin was omitted from the buffers. Cells were incubated with the primary antibodies (SPR antiserum 11884-5, 1:500 or 1: 1000; Flag M2 antibody, 10 j&ml) in the same buffer for 4 hr at 37°C. Cells were washed and incubated with secondary antibodies (swine anti-rabbit IgG FITC, rabbit anti-mouse IgG FITC, or rabbit anti-mouse IgG TRITC, all 1: 100 or 1:200) for 2 hr at room temperature. The coverslips were washed and mounted. Controls included staining cells transfected with vector alone, preabsorption of the diluted primary antibodies with SPR,,,,,), or with the Flag peptide (10 PM) overnight at 4°C prior to staining, and replacement of the primary antibodies with normal rabbit serum. Cells were examined using a Zeiss Axioplan microscope with fluorescein (Zeiss 4879 10, 450-490 nm excitation, 5 15-565 nm emission, 510 nm chromatic beam splitter) and rhodamine (Zeiss 487915, 546 nm excitation, ~590 nm emission, 580 nm chromatic beam splitter) filters.
Adult, male, pathogen-free rats (F344,260-280 gm) were anesthetized with sodium pentobarbital (50 mg/kg, i.p.) and perfused through the heart with 40 gm/liter paraformaldehyde in PBS. The ileum and lumbar spinal cord were removed and placed in paraformaldehyde overnight at 4°C. The tissue was washed in PBS, placed in 300 gm/liter sucrose in PBS overnight at 4°C and embedded in OCT. Frozen sections (1 O-30 pm) were cut and incubated for 12 hr with either SPR antiserum 11884-5 (I : 1000) anti-substance P (1: 1 000), or SPR antiserum 11884-5 (1: 1000) preincubated with 10 FM of SPR,,,,,, overnight at 4°C before staining. The antiserum was diluted in PBS containing 3 ml/liter Triton X-100 to permeablize the cells to the antibodies. There was no detectable staining in the absence of the detergent. Sections were incubated with a biotinylated secondary antibody and then with peroxidase conjugated with avidin-biotin complex. Antibody binding was detected using diaminobenzidine.
Western blotting. A membrane fraction was prepared (Bunnett et al., 1985) . All procedures were at 4°C and buffers contained 0.2 gm/liter sodium azide. Transfected KNRK cells were rinsed in PBS, lifted from tissue culture dishes with Cell Dissociation Buffer, pelleted, and homogenized in -5 ml of 50 mM Tris, pH 7.5, containing 10 mM PMSF and 1 FM pepstatin A. The homogenate was centrifuged (1000 x g,,,, 5 min) to remove cellular debris and the supernatant was ultracentrifuged (100,000 x g,,,,,, 45 min). The pellet was resuspended in 50 mM Tris, pH 7.5, and centrifuged (100,000 x g,,,,,, 45 min). The pellet was homogenized in 50 mM Tris, pH 7.5, containing 0.5 M NaCl and centrifuged (100,000 x g,,,, 45 min). This step was repeated. The final pellet was suspended in 50 mM Tris, pH 7.5, and stored at -70°C. Total protein in the membrane preparation was determined by the dye binding assay method of Bradford (1976) . Membranes (20 Kg total protein) from each preparation were separated on a 90 gm/liter polyacrylamide gel under denaturing and reducing conditions (Laemmli, 1970) and electrophoretically transferred to nitrocellulose (Bumette, I98 1) . Filters were incubated with the SPR antiserum 11884-5 (1: 1000) overnight at 4°C washed, and then incubated with goat anti-rabbit IgG conjugated to alkaline phosphatase (1: 1000) for 1 hr at room temperature. The filters were washed and the bound antibody was visualized using liquid purple according to the manufacturer's protocol. To ensure that each lane contained equal amounts of protein, duplicate lanes were stained with Ponceau S according to the manufacturer's protocol to stain the total protein. Controls included use of cells transfected with vector alone and preabsorption of the diluted primary antiserum with SPR,,,,,, (10 PM) overnight at 4°C prior to incubation with the filter. Substance P binding. Cells grown in plastic wells were washed with Hanks' balanced salt solution (HBSS) containing 1 gm/liter bovine serum albumin (BSA) and incubated in the same buffer for 1 hr at 4°C or 37°C to reduce nonspecific binding. Cells were incubated in 250 ~1 of HBSS-BSA containing 100 PM Bolton-Hunter labeled 'Y-substance P in the presence and absence of 1 PM unlabeled substance P (to assess nonspecific binding) for graded times at 4°C or 37°C. After incubation, the cells were washed three times in PBS on ice, lysed in 250 ~1 of 0.5 M NaOH for 30 min at room temperature, and counted. In the competition experiments, the cells were incubated with unlabeled substance P(lOm" to 10m6 M) for 10 min at 4°C before addition ofthe 1z51-substance P. Protease inhibitors were not used in binding experiments, as substance P degrading enzymes were not detected in membranes prepared from KNRK cells (N. W. Bunnett, unpublished observation).
Substance P-induced calcium mobilization. Cells grown in plastic wells were washed with HBSS-BSA and loaded with fura-Z/AM (2.5 FM in HBSS-BSA) in the dark for 20-50 min at 37°C. Cells were washed with HBSS-BSA and lifted from tissue culture dishes with cell dissociation buffer. Cells were pelleted (1000 x g, 5 min) and suspended in HBSS-BSA (0.25-0.5 x 10s cells per ml). The intracellular fura-Z/AM signals were immediately measured at both 340 and 380 nm excitation and 5 10 nm emission using a fluorimeter (F-2000, Hitachi Instruments, Irvine, CA). Cells were exposed to a single concentration of substance P( IO-" to 10mh M), lysed with 2 ml/literTriton X-100, and thenexposed to 5 mM EGTA. The relative [Ca2 I.], was calculated, as described previously (Grynkiewicz et al., 1985) . All experiments were staggered such that the time between washing the loaded cells and adding substance P was about 10 min. branes prepared from the rat brain and submaxillary glands but not liver and
spleen.
Radioimmunoassay of the SPR Approximately 50% of 1251-SPR,,,,,, was bound at a dilution of antiserum 11884-5 of 1:70,000. Nonradioactive SPR,,,,,, inhibited binding of 'Z51-SPR,,,,,, with an IC,, of -10 PM (Fig.  2) . To determine whether the antiserum recognized the SPR in transfected cells, KNRK SPR and KNRK CMV (control) cells were grown to confluence in 12-well plates and then each well was extracted with 0.2 ml of 1 ml/liter Triton X-100 and assayed for SPR by radioimmunoassay. Simultaneously, the B,,, was determined by Scatchard analysis of equilibrium 1251-substance P binding in KNRK SPR cells seeded and cultured identically. The SPR was undetectable in extracts of KNRK CMV control cells, assessed by radioimmunoassay. Immuoreactive SPR was detected in extracts from KNRK SPR, and there were approximately 75,000 receptors/cell. Scatchard analysis of radioligand binding revealed 80,000 receptors/cell. These results suggest that the SPR antiserum recognized the intact SPR receptor as well as the receptor fragment, SPR,,,,,,, used to generate the antiserum. To determine if the radioimmunoassay was sensitive enough to detect SPR in normal tissues, membranes were prepared from two rat organs that express high levels of the SPR (brain and submaxillary gland) and two rat organs that do not have detectable amounts of the receptor (liver and spleen) as controls. Membrane extracts from the liver or spleen did not inhibit LZ51-SPR,,,,,, binding to antiserum 11884-5 (Fig. 2) . In contrast, membrane extracts from the brain or submaxillary gland inhibited 1251-SPR,,,,,, binding in a concentration-dependent manner (Fig. 2) .
Immunohistochemical localization of SPR and Flag in transfected cells
The Flag epitope and the SPR were localized in transfected cells by immunohistochemistry.
The Flag M2 antibody stained the plasma membrane of KNRK Flag-SPR cells (Fig. 3A) but not KNRK CMV cells (Fig. 3C) (Fig. 3E) and was absent when the Flag M2 antibody was replaced with normal rabbit serum (not shown). The weak cytoplasmic staining was still observed in the controls and was judged to be nonspecific.
The anti-SPR antiserum 11884-5 stained the plasma membrane of KNRK SPR cells (Fig. 3B) and KNRK Flag-SPR cells (not shown) but not KNRK CMV cells (Fig. 30) . There was weak cytoplasmic staining of the KNRK SPR, KNRK Flag-SPR, and KNRK CMV cells, but strong cell-surface staining was observed only in the KNRK SPR and KNRK Flag-SPR cells. Cell-surface staining was abolished by preabsorption of the anti-SPR antiserum 11884-5 with SPR,,,,,, (10 PM) (Fig.  3F ) and was absent when the antiserum was replaced with normal rabbit serum (not shown). The weak cytoplasmic staining was still observed in the controls and was judged to be nonspecific.
The KNRK Flag-SPR cells and KNRK CMV cells were examined by simultaneous double labeling immunohistochemis- try. The Flag M2 (mouse monoclonal) and anti-SPR antiserum 11884-5 (rabbit polyclonal) were used as primary antibodies and TRITC-conjugated goat anti-mouse IgG and FITC-conjugated swine anti-rabbit IgG were used as secondary antibodies. The Flag M2 antibody and the anti-SPR antiserum 11884-5 both stained the plasma membranes of the same KNRK Flag-SPR cells (Fig. 4A,B) . When one or the other primary antibody was omitted staining was absent, and the plasma membrane of the KNRK CMV cells was unstained (not shown).
Immunohistochemical localization of SPR in rat tissues
In the lumbar spinal cord of the rat, immunoreactivity to SPR was present on dendrites within the substantia gelatinosa (Fig.  54 ) and adjacent to the central canal, and on cell bodies and dendrites in the intermediolateral region (Fig. 5B) . Substance P immunoreactivity in adjacent sections was localized to nerve fibers in the substantia gelatinosa (Fig. 5C ) and in dendrites in the intermediolateral region (Fig. 5D ). When the SPR antibody was preincubated with SPR,,,,,,, there was no specific labeling in adjacent sections of the spinal cord (Fig. 5E,F) .
In the ileum, immunoreactivity to SPR was present on the surface of some cell bodies and dendrites of neurons in the myenteric plexus (Fig. 6A) . Some cell bodies and nerve fibers in the submucous plexus were also immunoreactive to SPR (Fig.  6B ), but these cells were less abundant than those in the myenteric plexus. Cells at the base of the circular muscle layer, adjacent to the submucous plexus, were strongly immunoreactive for SPR (Fig. 6.4,D) . These cells resemble the "small dark muscle cells" referred to by Baluk and Gabella (Gabella, 1974; Baluk and Gabella, 1987) . In addition, SPR immunoreactivity was present in occasional large multiprocessed cells in the circular muscle layer (Fig. 6F) . These cells remain to be identified. Substance P immunoreactivity in adjacent sections was localized to nerve cell bodies and fibers in the myenteric and submucous plexus and to nerve fibers innervating the circular muscle (Fig.  6C) . When the SPR antibody was preincubated with SPR,,,,,,, there was no specific labeling in adjacent sections of the ileum (Fig. 6E) .
Western blotting Western blotting was used to determine the apparent molecular mass of the SPR in transfected cells. Attempts to use the Flag M2 antibody for Western blotting were unsuccessful. However, the SPR antiserum 11884-5 recognized broad protein bands with an apparent molecular masses from 70 to over 150 kDa in membranes prepared from KNRK Flag-SPR cells (Fig. 7 , lane 2). These protein bands were not detected when membranes prepared from KNRK CMV cells were analyzed (Fig. 7, lane  1) . In addition, apart from a minor band, they were not detected in membranes from KNRK Flag-SPR cells when the primary antiserum was preabsorbed by incubation with SPR,,,,,, (10 PM) (Fig. 7, lane 4) . Staining of duplicate filters with Ponceau S confirmed that the same amount of protein was analyzed in each lane (Fig. 7 , lanes 5 and 6).
Substance P binding To confirm that substance P interacted normally with the chimerit Flag-SPR, the kinetics of substance P binding were examined in KNRK cells expressing the native and chimeric receptor. 12SI-substance P binding to KNRK Flag-SPR cells and KNRK SPR cells was specific, temperature dependent (Fig. 8A,B) , and reversible (not shown). Specific binding was rapid at 37°C Figure 5 . Photomicrographs of adjacent sections of the dorsal horn (4, C, E) and of the intermediolateral region (B, D, F) of the lumbar spinal cord of the rat. Immunoreactivity to SPR is present on dendrites in the substantia gelatinosa (A) and on dendrites and cell bodies in the intermediolateral region (B). A high density of substance P-immunoreactive nerve fibers is present in an adjacent section of the dorsal horn (C), whereas few substance P-immunoreactive fibers are present in the intermediolateral region (D). Specific staining with the SPR antiserum 11884-5 was abolished by preincubation with SPR,,,,,, (E, F). Scale bars: A, C, and E, 100pm; B, D, and F, 50 pm. Figure 6 . Photomicrographs of the muscular layer of the ileum of the rat. Immunoreactivity to SPR is present on the surface of some cell bodies and dendrites in the myenteric plexus (A and D, arrows), and on a few cell bodies and dendrites of the submucous plexus (B, arrow). Cells at the base of the circular muscle layer, adjacent to the submucous plexus, are strongly immunoreactive for SPR and are thought to resemble "small dark muscle cells" (A. B, and D, arrowheads). Immunoreactivity to SPR is also present in some large, multiprocessed cells in the circular muscle layer (F). Substance P immunoreactivity is present in some cell bodies in the myenteric plexus (C, arrows) and in some nerve fibers in the myenteric and submucous plexus, and circular muscle (arrowheads). Staining with the SPR antiserum 11884-5 was abolished by preincubation with SPR,,,_ 40, (E). A, C, and E are adjacent sections. Staining of tissue mast cells in the submucosa was observed in controls and is thus considered to be nonspecific (E, arrows). A-D and F were taken with Nomarski optics. Scale bar, 50 pm. reaching a peak at 20 min and then declining. At 37°C the nonspecific binding at the time of the peak was similar (~5% total binding) for both KNRK Flag-SPR cells and KNRK SPR cells. Specific binding was slower at 4"C, reaching a peak at 60-80 min and then declining. At 37°C the nonspecific binding at the time of the peak was similar (< 10% total binding) for both KNRK Flag-SPR cells and KNRK SPR cells. The displacement of saturable 1251-substance P binding by unlabeled substance P was examined at 4°C at the time of peak binding (Fig. 8C) . The competition curves were superimposable for KNRK Flag-SPR and KNRK SPR cells. The apparent affinities (Kd values) of the SPR and Flag-SPR for substance P were determined by Scatchard analysis. The apparent Kd was 5.63 + 1.54 nM for KNRK Flag-SPR cells and 6.15 + 2.09 nM for KNRK SPR cells.
Substance P-induced calcium mobilization To determine whether the Flag-SPR was fully functional, substance P-induced calcium mobilization was examined in KNRK cells expressing the native and chimeric receptor. Substance P induced a prompt increase in [Ca*+]; in both KNRK Flag-SPR cells and KNRK SPR cells that peaked within w 10 set and diminished to prestimulatory values within 50-150 set (depending on the concentration) (Fig. 9A,B) . The threshold substance P concentration for stimulation was 5 x 10-l' M to lo-lo M, and the maximal response was observed at 1 O-' M substance P (Fig. 9C) . The potency or EC,, calculated from the concentration-response curves was 0.66 nM for KNRK Flag-SPR cells and 0.76 nM for KNRK SPR cells.
Discussion
The present study describes two complementary strategies for using antibodies to study the rat SPR. In the first strategy, an antibody was raised in rabbits to a synthetic fragment corre- .30k
sponding to the C-terminal 15 amino acid residues of the rat SPR coupled to bovine thyroglobulin. The antiserum was then used to localize the SPR in transfected cells and tissue sections by immunohistochemistry and to quantify the receptor by radioimmunoassay of solubilized membranes. The antiserum also recognized protein bands that may represent the receptor, on Western blots of membranes prepared from transfected cells. The second strategy involved generating a chimeric receptor, comprising a small hydrophilic Flag peptide genetically engineered to the N-terminus of the rat SPR. The Flag-SPR chimera was expressed in mammalian cells and found to be fully functional. A monoclonal antibody to the Flag peptide was used to localize the chimeric receptor in transfected cells by immunohistochemistry. Four observations suggest that the SPR antiserum specifically recognized the rat SPR. First, the antiserum localized immunoreactive SPR by immunohistochemistry to the plasma membrane of KNRK cells expressing functional rat SPR. Specific staining was confined to the surface of the cells, the expected location of the SPR, and there was no specific cytoplasmic staining. KNRK cells transfected with vector alone do not express detectable SPR, determined by radioligand binding and calcium mobilization measurements (Mitsuhashi et al., 1992) , and were not stained by the SPR antiserum. Second, the SPR antiserum localized immunoreactive SPR to neurons in the dorsal horn of the spinal cord and to neurons and muscle cells in the ileum. Cells containing immunoreactive SPR in both locations were richly supplied with nerve fibers containing immunoreactive substance P. These tissues are well-defined sites of expression of the SPR, assessed by autoradiography using radiolabeled ligands and by functional experiments (Barth0 and Holzer, 1985; Burcher et al., 1986; Mantyh et al., 1989; Helke et al., 1990; Otsuka and Yoshioka, 1993) . Staining of transfected cells ex- pressing the SPR and of tissue sections was abolished by preabis 46.3 kDa (Yokota et al., 1989; Hershey and Krause, 1990) . sorption of the antiserum with SPR,,,,,,. Third, the antiserum However, there are two potential N-linked glycosylation sites recognized broad protein bands in Western blots of membranes at the N-terminus, suggesting that the molecular mass of the prepared from KNRK cells expressing the SPR. These are likely native receptor may exceed 46.3 kDa. Previously, proteins to represent the SPR because they were not detected in cells thought to correspond to the SPR have been identified by crosstransfected with the vector alone without the SPR insert and linking experiments in a variety oftissues and cell lines. Putative because the signal was quenched when the primary antiserum SPR proteins with molecular masses of 44 kDa in sheep inteswas preabsorbed with SPR,,,,,,. It was not possible to detertinal muscle (Keefer and Mong, 1990) 56 kDa in rat submaxmine unequivocally the molecular mass of the receptor by Westillary gland (Boyd et al., 199 1) , 76 kDa in guinea pig lung (Coats ern blotting because the antiserum recognized several broad and Gerard, 1989) (Gilbert et al., 1992) 4.5-80 kDa in transfected CHO cells, and 56-76 kDa in rat striatal membranes (Shigemoto et al., 1993) using antibodies to fusion proteins of the SPR. Immunoreactive SPR was detected with a molecular mass of 90 kDa in the rat cortex using antibodies raised to a fragment of the receptor (Moussaoui et al., 1992) . It is probable that variable degrees of glycosylation and proteolytic degradation may account for these different estimates in molecular mass of the SPR (McGillis et al., 1987) . Furthermore, glycosylation may affect antigenicity of the receptor for different antibodies. The fourth observation supporting specificity of the SPR antiserum used in the present experiments is that it recognized the SPR fragment and the intact receptor in radioimmunoassays.
The binding of iodinated SPR,,,,,, was displaced in a parallel manner by membranes from the rat brain and submaxillary gland, tissues known to express high levels of the SPR (Helke et al., 1990; Otsuka and Yoshioka, 1993) . Membranes from the liver and spleen, tissues with undetectably low levels of SPR expression, did not displace binding. In addition, binding was displaced by extracts from KNRK SPR cells but not KNRK CMV control cells.
The Flag M2 antibody localized the immunoreactive Flag peptide to KNRK cells expressing the Flag-SPR chimera, as assessed by immunohistochemistry.
Staining was confined to the surface of the cell and was not detected in the cytoplasm. Cells expressing the native SPR or transfected with the vector alone were not stained by the antiserum, and the staining of the KNRK Flag-SPR cells was abolished by preabsorption of the Flag M2 antibody with Flag peptide, confirming the specificity of the antibody.
Previously, chimeric molecules have been generated by coupling the Flag peptide to cytokines (Hopp et al., 1988; Prickett et al., 1989) C5a anaphylatoxin (Gerard and Gerard, 1990 ) the leukocyte platelet-activating factor receptor (Gerard and Gerard, 1992) and thyroid hormone receptors (Zhang et al., 199 1) . Monoclonal antibodies to the Flag have been used to purify the chimeric molecules by affinity chromatography, for Western blotting and for immunohistochemistry (Hopp et al., 1988; Prickett et al., 1989; Gerard, 1990, 1992; Zhang et al., 1991) . To our knowledge, the present report is the first to describe the generation of a Flag-SPR chimera and the use of the Flag antibody to study the chimeric receptor in transfected cells by immunohistochemistry.
This approach may permit the immunochemical characterization of a chimera of the Flag peptide and any neuropeptide receptor expressed in transfected cells. One advantage of this approach is that it permits the immunochemical examination of a Flag-receptor chimera using a single well-characterized Flag antibody, thus avoiding the uncertain process of generating receptor specific antibodies. A second advantage is that the hydrophilic Flag peptide projects extracellularly and is thus accessible to the antibody for use in cell sorting.
For the strategy of using a chimeric receptor to be of value, it is important to verify that the Flag-receptor chimera is fully functional. In the present investigation this was confirmed by comparing the binding characteristics and the calcium response of KNRK cells expressing the native SPR and the Flag-SPR chimera. The time course for binding 1~51-substance P was identical for both KNRK SPR and KNRK Flag-SPR cells. In addition, the competition curves were superimposable and the affinity of substance P for the native and chimeric SPR was the same (6.15 nM and 5.63 nM, respectively). Substance P induced a prompt increase in the concentration of intracellular calcium in cells expressing native SPR and Flag-SPR. In both cases the concentration-response curves were superimposable, with similar EC,, values ((0.76 nM and 0.66 nM, respectively). The Kd and EC,, are similar to those previously reported for the rat SPR in other cells (Yokota et al., 1989; Helke et al., 1990; Hershey and Krause, 1990; Mitsuhashi et al., 1992; SudduthKlinger et al., 1992) .
In summary, we have described two methods for studying the rat SPR using antibodies to the native receptor and to a chimeric receptor expressed in mammalian cells. These antibodies should prove useful for localizing and quantitating the SPR in cells and tissues and for investigating modifications to the receptor during signal transduction.
